Switzerland· 69132001
Imdylltra 1 mg, Pulver für ein Konzentrat und Stabilisatorlösung zur Herstellung einer Infusionslösung
A tarlatamab product containing tarlatamabum, registered in Switzerland by Amgen Switzerland AG and dispensed under Swissmedic category A. The same ATC class is registered in 12 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Tarlatamab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FX33 (tarlatamab), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Tarlatamab · ATC L01FX33
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Swissmedic (Switzerland)- Active substance
- tarlatamabum
- Manufacturer
- Amgen Switzerland AG
- Country
- Switzerland (CH)
- ATC code
- L01FX33
- ATC class
- Tarlatamab
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tarlatamab in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumImdylltra 1 mgAmgen Europe
- SpainIMDYLLTRA 1 MG POLVO PARA CONCENTRADO Y SOLUCIÓN PARA SOLUCION PARA PERFUSIONAmgen Europe B.V.
- FinlandImdylltraAmgen Europe B.V.
- United KingdomImdylltra 1mg powder for concentrate and solution for solution for infusion vialsAmgen Ltd
- IcelandImdylltraAmgen Europe B.V.*
- NorwayImdylltraAmgen Europe B.V.
- PolandIMDYLLTRAAmgen Europe B.V.
- SwedenIMDYLLTRA 1 mg Pulver till koncentrat och lösning till infusionsvätska, lösningAmgen Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Imdylltra
- Norway · Imdylltra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/39a83440-ff6c-489d-9d44-d1d95a1d90a9 GET /v1/drugs/39a83440-ff6c-489d-9d44-d1d95a1d90a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Biotechnologika"
}See everything about tarlatamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.